Mainly, two categories include the FDA-approved prescription drugs for the treatment of patients with AD, such as cholinesterase inhibitors, which are used for mild to moderate AD, and an inhibitor for NMDA receptors, memantine, for the treatment of moderate to severe AD. Here, BCHE is linked to Alzheimer disease.